Explorer les evidences

14 %Infection with Schistosoma mansoni was associated with a 14% higher estimated proportion of active TB cases in HIV-infected individuals.

Kenyatuberculoseobservé 2014 and 2017publié 2021Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 2 observations

8,3 %Among HIV-infected patients in Central Kenya, those on TB treatment during their last known visit decreased from 8.3% in 2004 to 3.9% in 2014.

Kenyatuberculose · VIH/sidaobservé 2004 to 2014publié 2021BMC infectious diseasesPubMeddocument de 10 observations

95,6 %GeneXpert sensitivity in smear positive culture positive specimens was 95.6%, compared to 97.2% for ZN microscopy and 97.2% for LED fluorescent microscopy.

Kenyatuberculoseobservé 2013-2014publié 2019African Journal of Health SciencesOpenAlexdocument de 6 observations

35 %Tuberculosis/HIV coinfection rate was 35% among the cohort of 291 patients in Vihiga County.

Kenyatuberculose · VIH/sidapublié 2023African health sciencesPubMeddocument de 6 observations

0,4 %Among HIV-positive tuberculosis patients in Western Kenya, INH + KAN polyresistant strains occurred in 0.4% of cases.

Kenyatuberculosepublié 2021BMC infectious diseasesPubMeddocument de 23 observations

79 %During SLATE II, 79% of patients with ≥1 tuberculosis (TB) symptom were tested for TB.

Kenyatuberculoseobservé SLATE IIpublié 2020BMJ openPubMeddocument de 12 observations

16,4 %Resistance to rifampicin (RIF) among HIV-negative tuberculosis patients in Western Kenya was 16.4%.

Kenyatuberculosepublié 2021BMC infectious diseasesPubMeddocument de 23 observations

28,5 %Resistance to isoniazid (INH) among HIV-negative tuberculosis patients in Western Kenya was 28.5%.

Kenyatuberculosepublié 2021BMC infectious diseasesPubMeddocument de 23 observations

0,3 %Capreomycin resistance among HIV-negative tuberculosis patients in Western Kenya was 0.3%.

Kenyatuberculosepublié 2021BMC infectious diseasesPubMeddocument de 23 observations

56,7 %Sputum smear microscopy (SSM) registered a sensitivity of 56.7% for tuberculosis diagnosis among people living with HIV in Nairobi, Kenya.

Kenyatuberculoseobservé 2022-2023publié 2024PloS onePubMeddocument de 7 observations

35,2 CqAmong participants with tuberculosis, mean oral swab threshold quantitation cycle value was 35.2 at enrollment visit.

Kenyatuberculosepublié 2022PloS onePubMeddocument de 10 observations

29 casesTwenty-nine women were diagnosed with tuberculosis.

Kenyatuberculoseobservé between March 2000 and January 2010publié 2017Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument de 9 observationsDOI 10.1097/qai.0000000000001461

4,3 %Among TB patients, 4.3% were lost to follow-up.

Kenyatuberculoseobservé 2012–2020publié 2023BMC infectious diseasesPubMeddocument de 11 observations

26,3 %Mtb-specific non-IFN-γ+ responses (IL-2+ and/or TNF+) were more common than IFN-γ+ responses (26.3% vs 10.3%).

Kenyatuberculosepublié 2026The Journal of infectious diseasesPubMeddocument de 4 observations

99 %Uptake of cotrimoxazole prophylaxis among TB/HIV co-infected patients was 99%.

Kenyatuberculose · VIH/sidaobservé 2012–2020publié 2023BMC infectious diseasesPubMeddocument de 11 observations

0,3 %Ethionamide resistance among HIV-negative tuberculosis patients in Western Kenya was 0.3%.

Kenyatuberculosepublié 2021BMC infectious diseasesPubMeddocument de 23 observations

5,7 %Scedosporium spp. were isolated from 5 out of 88 fungal-positive sputum samples (5.7%) among PTB patients in Kenya.

Kenyatuberculosepublié 2022BMC infectious diseasesPubMeddocument de 14 observations

96,4 %Among children and adolescents living with HIV in central Kenya, 96.4% did not have tuberculosis symptoms.

Kenyatuberculose · VIH/sidapublié 2022AIDS research and human retrovirusesPubMeddocument de 18 observations

98 %Among children living with HIV aged <15 years newly enrolled in HIV care in eight HIV clinics in western Kenya, 98% (n = 841) underwent screening for TB symptoms and IPT eligibility between September 2015 and July 2019.

Kenyatuberculoseobservé September 2015 through July 2019publié 2022Journal of the International AIDS SocietyPubMeddocument de 7 observations

2,4 hazard_ratioHIV infection was associated with a 2.40-fold higher hazard of death during TB treatment compared to HIV-negative status.

Kenyatuberculose · VIH/sidaobservé 2012–2020publié 2023BMC infectious diseasesPubMeddocument de 11 observations

26,6 %The number of notified tuberculosis cases decreased by 26.6% during the pandemic onset in Kenya.

Kenyatuberculosepublié 2022The Lancet. Global healthPubMeddocument de 12 observations

62 individualsAmong 152 children with HIV, 40.8% (62) were tuberculosis–antiretroviral therapy treated.

Kenyatuberculose · VIH/sidapublié 2024AIDS (London, England)PubMeddocument de 5 observations

84,5 %Sputum smear microscopy (SSM) recorded a positive predictive value of 84.5% for tuberculosis diagnosis among people living with HIV in Nairobi, Kenya.

Kenyatuberculoseobservé 2022-2023publié 2024PloS onePubMeddocument de 7 observations

155 assaysNinety-seven infants had 155 urine isoniazid metabolite assays performed in an infant tuberculosis prevention trial in Kenya.

Kenyatuberculosepublié 2021The Pediatric infectious disease journalPubMeddocument de 2 observations

18,4 %Out of the 37 (18.4%) who returned for follow up at 2 weeks, none was either sputum smear positive or Gene-Xpert positive.

Kenyatuberculoseobservé February 2013 to February 2014publié 2019African Journal of Health SciencesOpenAlexdocument de 5 observations